Pilot study of the conversion from tacrolimus to cyclosporine microemulsion in liver transplant patients presenting with new onset diabetes after the 3rd month post-transplant
Phase of Trial: Phase IV
Latest Information Update: 31 Jan 2011
At a glance
- Drugs Ciclosporin (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 31 Aug 2018 Biomarkers information updated
- 31 Jan 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 31 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.